Evidence map›Paper›PMID 42281991›Full record

ArticleResearch square2026

Virus-specific CD8 T cells rapidly populate and persist in skull bone marrow after brain infection.

Asma Hassani, Fang Jin, Michael D Forston, Armeta Hadjimirzaei, Cody L Lewis, Carley A Owens, Javonte S Thelwell, Marina Seady, Mark A Maynes, Zichen Tian and 3 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Asma HassaniDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.ORCID 0000-0001-7792-2140
Fang JinDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.
Michael D ForstonDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.ORCID 0000-0001-7759-225X
Armeta HadjimirzaeiGraduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905 USA.
Cody L LewisDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.
Carley A OwensDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.
Javonte S ThelwellGraduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905 USA.
Marina SeadyDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.
Mark A MaynesDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.
Zichen TianGraduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905 USA.
Michael J HansenDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.
Katayoun AyasoufiDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.
Aaron J JohnsonDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 USA.

Funding

CD8 T cell mediated disruption of Blood Brain Barrier Tight JunctionsR01NS103212 · NINDS · MAYO CLINIC ROCHESTER · PI Aaron J Johnson · 2017 to 2026
$4.6M
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and TauopathyR01NS122174 · NINDS · MAYO CLINIC ROCHESTER · PI JOHNSON, AARON J · 2024 to 2025
$1.2M
NINDS NIH HHS R01 NS103212NINDS NIH HHS R01 NS122174
6 · The paper itself

Abstract

Skull bone marrow (BM) is a recently identified site for immune activation responsive to CNS insults. The extent to which adaptive immunity is generated through skull BM is poorly understood. In this study, we evaluated how skull BM supports the early expansion of antiviral CD8 T cells during acute neurotropic virus infection. Virus antigen-specific CD8 T cells were rapidly identified in skull BM at a rate comparable to lymphoid compartments during acute Theiler's murine encephalomyelitis viral (TMEV) infection. We therefore employed MHC class I conditional knockout mice and demonstrated the necessity of CD11c+ antigen-presenting cells (APCs) for the generation of various subsets of TMEV-specific CD8 T cells in skull BM. Importantly, the early expansion of skull BM-derived antiviral T cells was impeded by FTY720 treatment and restored upon shared circulation with a mouse exhibiting intact antigen presentation by CD11c+ APCs. Additionally, TMEV-specific CD8 T cells were retained in skull BM during both chronic CNS infection and long after infection has been resolved. Overall, we determined that skull BM responds to acute neurotropic viral infection through the rapid recruitment of virus-specific CD8 T cells primed in the periphery before serving as a reservoir for immunologic memory.

Identifiers

PMID42281991
PMCPMC13252567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.